Background: Leishmaniasis is a major tropical and subtropical parasitic disease. Sodium stibogluconate, N-methyl -D-glucamine antimoniate, amphotericin B, pentamidine, and ketoconazole are drugs used to treat this disease. Some of these drugs cause severe adverse side effects and treatment failures
S -ADENOSYLMETHIONINE SYNTHESIS IN LEISHMANIA INFANTUM PROMASTIGOTES
✍ Scribed by R.M Reguera; Y Pérez-Pertejo; C Ordóñez; J.C Cubrı́a; B.L Tekwani; R Balaña-Fouce; D Ordóñez
- Book ID
- 102567606
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 110 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1065-6995
No coin nor oath required. For personal study only.
✦ Synopsis
Methionine adenosyltransferase (MAT), S ‐adenosylmethionine (AdoMet), and S ‐adenosylhomocysteine (AdoHcy), have been analysed at different time‐points during the growth curve of Leishmania infantum. MAT activity and AdoMet content peaked in the lag and early log phases, whereas higher levels of AdoHcy were found in stationary phase cells. MAT activity of cell extracts displayed hyperbolic kinetics for both its substrates, l ‐methionine and ATP, with km values of 35μm and 5m m, respectively. MAT has an absolute requirement for divalent cations, and is dependent on sulfydryl protective agents. Unlike other sources, L. infantum MAT activity seems to be transcriptionally regulated, with an accumulation of MAT‐mRNA during rapid growth periods of promastigotes.
📜 SIMILAR VOLUMES
Some metK mutants of Salmonella typhimurium with constitutive methionine biosynthesis have no detectable S-adenosylmethionine (SAM) synthetase, the enzyme which converts methionine to SAM, the postulated corepressor of the methionine pathway. However, these mutants are not auxotrophic for SAM, an es